Elanco Animal Health Inc. Announces Executive and Board Changes

Ticker: ELAN · Form: 8-K · Filed: Mar 17, 2025 · CIK: 1739104

Elanco Animal Health Inc 8-K Filing Summary
FieldDetail
CompanyElanco Animal Health Inc (ELAN)
Form Type8-K
Filed DateMar 17, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: executive-changes, board-changes, regulation-fd

Related Tickers: ELAN

TL;DR

Elanco's board and execs are shuffling; expect strategic shifts.

AI Summary

Elanco Animal Health Incorporated announced on March 11, 2025, a significant event involving the departure of directors or certain officers, the election of new directors, and the appointment of certain officers. The filing also includes information on compensatory arrangements for certain officers and a Regulation FD disclosure. Additionally, financial statements and exhibits related to these events were filed.

Why It Matters

Changes in executive and board leadership can signal shifts in company strategy, operational focus, or financial direction, impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in key leadership and potential shifts in strategy can introduce uncertainty and impact future financial performance.

Key Players & Entities

  • Elanco Animal Health Incorporated (company) — Registrant
  • March 11, 2025 (date) — Date of Earliest Event Reported

FAQ

What specific roles have seen departures or appointments within Elanco Animal Health Inc.?

The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but does not specify the exact roles in this summary.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on March 11, 2025.

What is the primary business of Elanco Animal Health Inc. according to the filing?

Elanco Animal Health Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.

What is the principal executive office address for Elanco Animal Health Inc.?

The principal executive offices are located at 2500 Innovation Way, Greenfield, Indiana 46140.

What other types of information are included in this 8-K filing besides executive changes?

The filing also includes information on compensatory arrangements of certain officers, Regulation FD disclosure, and financial statements and exhibits.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 17, 2025 regarding Elanco Animal Health Inc (ELAN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.